President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators ...
Marty Makary, President Donald Trump’s pick to oversee US food and drug regulation, faced pointed questions in a Senate ...
Days after the U.S. FDA cancelled an annual meeting to discuss the makeup of the following season's flu vaccine, FDA ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Questioned by senators at a Thursday hearing, President Trump's FDA nominee said he would reevaluate which scientific topics require an advisory committee's input.
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese people without diabetes and another one for people with diabetes.
If confirmed to lead the Food and Drug Administration, will Dr. Marty Makary carry out Robert F. Kennedy Jr.’s plans to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results